miR-۳۴b-۵p Overexpression Differentially Affects Immunomodulation and Epithelial Genes in Breast Cancer Cells

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 34

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJABBR-14-5_005

تاریخ نمایه سازی: 21 آبان 1405

چکیده مقاله:

Triple-negative breast cancer (TNBC) and luminal breast cancer are biologically distinct subtypes with different mechanisms of progression and therapeutic responses. Tumor-mediated immune evasion and epithelial–mesenchymal transition (EMT) are key processes that contribute to tumor aggressiveness, particularly in TNBC. MicroRNAs (miRs) are emerging as important regulators of these pathways; however, the function of miR-۳۴b-۵p in modulating immune checkpoint genes and epithelial markers across breast cancer subtypes remains poorly understood. The human breast cancer cell lines MDA-MB-۲۳۱ and MCF-۷ were transfected with a miR-۳۴b-۵p mimic or a scrambled control oligonucleotide. miR-۳۴b-۵p expression was quantified, and the expression of immune checkpoint–related genes, programmed death-ligand-۱ (PD-L۱), transforming growth factor beta (TGFβ), and interleukin-۱۸ (IL-۱۸), and the epithelial marker, E-cadherin, was evaluated following miR-۳۴b-۵p overexpression. Transfection resulted in a robust increase in miR-۳۴b-۵p expression (approximately ۵,۸۰۰-fold increase). In MDA-MB-۲۳۱ cells, miR-۳۴b-۵p overexpression markedly upregulated PD-L۱, TGFβ, and IL-۱۸. In contrast, MCF-۷ cells showed no significant increases in PD-L۱, TGF-β, and IL-۱۸, but exhibited a strong induction of E-cadherin. The miR-۳۴b-۵p exerts subtype-specific effects in breast cancer, such that in TNBC, it promotes immune evasion-related genes, whereas in luminal cells, it enhances epithelial gene expression. These results suggest that miR-۳۴ influences molecular pathways differentially involved in breast cancer.

نویسندگان

- -

Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

- -

Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

- -

Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Xiong, X., Zheng, L.W., Ding, Y., Chen, Y.F., Cai, Y.W., ...
  • Orrantia-Borunda, E., Aguilar, L.E.A., Valdespino, C.A.R. Nanomaterials for breast cancer. ...
  • Tang, S., Ning, Q., Yang, L., Mo, Z., Tang, S. ...
  • Jardim, D.L., Goodman, A., de Melo Gagliato, D., Kurzrock, R. ...
  • Kallingal, A., Olszewski, M., Maciejewska, N., Brankiewicz, W., Baginski, M. ...
  • Almawash, S. Revolutionary cancer therapy for personalization and improved efficacy: ...
  • Rezaie, J., Chodari, L., Mohammadpour-Asl, S., Jafari, A., Niknam, Z. ...
  • Haist, M., Stege, H., Grabbe, S., Bros, M. The functional ...
  • Han, Y., Liu, D., Li, L. Pd-۱/pd-l۱ pathway: Current researches ...
  • Xue, V.W., Chung, J.Y.F., Córdoba, C.A.G., Cheung, A.H.-K., Kang, W., ...
  • Ma, T., Kong, M. Interleukin-۱۸ and− ۱۰ may be associated ...
  • Schwarzenbach, H. Clinical implementation of micrornas in cancer immunology. International ...
  • Fu, J., Imani, S., Wu, M.Y., Wu, R.C. Microrna-۳۴ family ...
  • Dong, L., Chen, F., Fan, Y., Long, J. Mir-۳۴b-۵p inhibits ...
  • Svoboda, M., Sana, J., Redova, M., Navratil, J., Palacova, M., ...
  • Lee, Y.M., Lee, J.Y., Ho, C.C., Hong, Q.S., Yu, S.L., ...
  • Hossain, M.M., Sultana, A., Barua, D., Islam, M.N., Gupta, A., ...
  • Ibrahim, M.A., Jalali, H., Azarnia, M. Exploring the impact of ...
  • Pandey, S., Yadav, P. Exploring the therapeutic potential of micrornas: ...
  • Cui, J.W., Li, Y., Yang, Y., Yang, H.K., Dong, J.M., ...
  • Antony, G.R., Augustine, P., Parambil, S.T., Littleflower, A.B., Kattoor, J., ...
  • Liu, Z., Yu, X., Xu, L., Li, Y., Zeng, C. ...
  • Liu, N., Jiang, X., Guo, L., Zhang, C., Jiang, M., ...
  • Liu, S., Liu, T., Jiang, J., Guo, H., Yang, R. ...
  • Nixon, B.G., Gao, S., Wang, X., Li, M.O. Tgfβ control ...
  • Li, L., Gao, L., Zhou, H., Shi, C., Zhang, X., ...
  • Taheri, M., Tehrani, H.A., Daliri, F., Alibolandi, M., Soleimani, M., ...
  • Park, I.H., Yang, H.N., Lee, K.J., Kim, T.S., Lee, E.S., ...
  • Janho dit Hreich, S., Hofman, P., Vouret-Craviari, V. The role ...
  • Shafran, J.S., Jafari, N., Casey, A.N., Győrffy, B., Denis, G.V. ...
  • Lu, L., Chen, Z., Lin, X., Tian, L., Su, Q., ...
  • Niu, H., Song, F., Wei, H., Li, Y., Huang, H., ...
  • نمایش کامل مراجع